Lynne McGrath, Vice President, US DRA Head of Oncology at Novartis, presented at last year's World Orphan Drug Congress USA on the topic â€˜A commitment to develop innovative treatments for neglected diseases.'
Do you want to learn more about:
- Setting up NIBR regardless of market size
- Expanding application to common diseases
- Transforming a promising candidate drug into a treatment reality that benefits patients
If so, you need to check out the video below: